Kelly Huibregtse, MD, MS
MSP Physician
Pediatrics
School of Medicine

Publications (1)

Top publication keywords:
3-IodobenzylguanidineChild, PreschoolAdolescentMyelodysplastic SyndromesCombined Modality TherapyRadiopharmaceuticalsNeoplasms, Second PrimaryAge of OnsetInfantAntineoplastic AgentsHematologic NeoplasmsNeuroblastomaRisk AssessmentYoung AdultChild

• Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine.
  European journal of cancer (Oxford, England : 1990) 2016 Huibregtse KE, Vo KT, DuBois SG, Fetzko S, Neuhaus J, Batra V, Maris JM, Weiss B, Marachelian A, Yanik GA, Matthay KK